ReviewMicrobiologyOpen2026
Pathogenic Mechanisms of V. vulnificus and Its Role in the Development of Sepsis.
Review in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathogenic Mechanisms of V. vulnificus and Its Role in the Development of Sepsis.MicrobiologyOpen · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Vibrio vulnificus (V. vulnificus) is a highly virulent marine pathogen responsible for severe infections, including necrotizing fasciitis and life-threatening sepsis, particularly in immunocompromised individuals. This review synthesizes current knowledge on V. vulnificus pathogenesis, focusing on key virulence factors such as cytolysins (VvhA and MARTX), iron acquisition systems, and immune evasion strategies. The bacterium's ability to induce rapid tissue damage, endothelial dysfunction, and systemic inflammation-mediated through cytokine storms and necroptosis-underpins V. vulnificus high mortality rates. Risk factors include chronic liver disease, diabetes, and environmental exposure to seafood harboring V. vulnificus or brackish water. Clinical management hinges on early diagnosis, prompt antibiotic therapy (e.g., doxycycline combined with third-generation cephalosporins), and surgical intervention for necrotizing infections. Despite advances, challenges persist, including antibiotic resistance and delayed diagnosis. Future directions emphasize novel therapeutics targeting virulence mechanisms, rapid diagnostics, and climate-adaptive public health strategies to curb the rising incidence of V. vulnificus infections in warming coastal ecosystems. This review underscores the urgent need for multidisciplinary approaches to mitigate the global burden of this formidable pathogen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.